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ABSTRACT The hepatic plasma membrane fatty acid-
binding protein (h-FABPpM) and the mitochondrial isoenzyme
of glutamic-oxaloacetic transaminase (mGOT) of rat liver have
similar amino acid compositions and identical amino acid
sequences for residues 3-24. Both proteins migrate with an
apparent molecular mass of 43 kDa on SDS/polyacrylamide
gel electrophoresis, have a similar pattern of basic charge
isomers on isoelectric focusing, are eluted similarly from four
different high-performance liquid chromatographic columns,
have absorption maxima at 435 nm under acid conditions and
354 nm at pH 8.3, and bind oleate with a Ka 1.2-1.4 X 107
M-1. Sinusoidally enriched liver plasma membranes and pu-
rified h-FABPpM have GOT enzymatic activity; the relative
specific activities (units/mg) of the membranes and purified
protein suggest that h-FABPpM constitutes 1-2% of plasma
membrane protein in the rat hepatocyte. Monospecific rabbit
antiserum against h-FABPpM reacts on Western blotting with
mGOT, and vice versa. Antisera against both proteins produce
plasma membrane immunofluorescence in rat hepatocytes and
selectively inhibit the hepatocellular uptake of [3HJoleate but
not that of [35S]sulfobromophthalein or [14C]taurocholate. The
inhibition of oleate uptake produced by anti-h-FABPpM can be
eliminated by preincubation of the antiserum with mGOT;
similarly, the plasma membrane immunofluorescence pro-
duced by either antiserum can be elimiated by preincubation
with the other antigen. These data suggest that h-FABPpM and
mGOT are closely related.
Glutamic-oxaloacetic transaminase (GOT; L-aspartate:2-
oxoglutarate aminotransferase, EC 2.6.1.1) is a well studied
enzyme that plays a major role in amino acid (1) and energy
(2) metabolism. Within eukaryotic cells it exists as distinct
cytoplasmic (3) and mitochondrial (4, 5) isoenzymes (sGOT
and mGOT, respectively) that catalyze essentially the same
reactions (6). Neither isoenzyme has any known role in the
cellular uptake of long-chain nonesterified fatty acids. By
contrast, hepatic plasma membrane fatty acid-binding pro-
tein (h-FABPpM), a plasma membrane protein of -40 kDa
that plays an as yet only partially defined role in cellular fatty
acid uptake, was described by our laboratory in 1985 (7).
Analogous plasma membrane FABPs were subsequently
isolated from the major tissues with high transmembrane
fatty acid fluxes (8), including jejunal mucosa (9), adipose
tissue (10), and cardiac muscle (11, 12). These proteins are
structurally distinct from and immunologically unrelated to
the smaller, cytoplasmic FABPs, designated FABPC (10, 13),
previously isolated from these same tissues (13).
Here we present data suggesting that h-FABPpM of rat liver
is closely related to mGOT. The similarities observed be-
tween mGOT and h-FABPpM raise interesting questions in
cellular and molecular biology.
MATERIALS AND METHODS
Protein Purification. mGOT was prepared from whole rat
liver homogenates (14). h-FABPpM was isolated from sinu-
soidally enriched liver plasma membranes (15, 16). Initially
(procedure A), proteins extractable from the membranes with
2 M NaCl were subjected to preparative isoelectric focusing.
Fractions with isoelectric points .9.0 were further purified
by oleate-agarose affinity chromatography followed by gel
permeation HPLC (8). More recently (procedure B), im-
proved recoveries were obtained with an alternative proce-
dure, in which salt-extracted membrane proteins were sep-
arated by HPLC over, sequentially, hydroxyapatite (Bio-Gel
HPHT) and hydrophobic-interaction (TSK phenyl 5 PW)
columns. Fractions containing h-FABPpM were collected and
examined for purity by gel permeation HPLC (Superose 12,
10/30 column, 300 mm x 10.0 mm i.d.), SDS/PAGE, and
isoelectric focusing. Details of this isolation procedure will be
published elsewhere (D. Stump, B.J.P., and P.D.B.).
Measurement ofGOT Activity. Activity of this enzyme was
determined with a commercially available kit (Sigma Diag-
nostics; procedure 58-UV) (17). When mGOT activity in
plasma membranes or liver homogenates was measured,
Triton X-100 was used to solubilize the proteins (18).
Analytical Procedures. Amino acid analysis (performed at
the Protein Sequencing Facility, Rockefeller University)
employed HCl hydrolysis and subsequent quantitation by a
Waters Picotag HPLC system. Sequencing (two samples
were sequenced, at the Protein Sequencing Facilities of Yale
and Rockefeller Universities) was performed on an Applied
Biosystems model 470A gas-phase sequencer, with on-line
phenylthiohydantoin determination by HPLC on an Applied
Biosystems model 120 analyzer. SDS/PAGE-Western blot-
ting and analytical isoelectric focusing were performed as
previously reported (8).
Preparation of Antibodies. Monospecific polyclonal anti-
bodies were produced in female New Zealand White rabbits
by intradermal injection of antigen in Freund's complete
adjuvant, followed by biweekly intramuscular booster injec-
tions of antigen emulsified in Freund's incomplete adjuvant,
as previously reported (7). Monoclonal antibodies against
h-FABPpM were obtained from hybridoma cell lines pro-
duced by the fusion of spleen cells from immunized BALB/c
mice with NS1 mouse myeloma cells (19). Hybridoma su-
Abbreviations: FABP, fatty acid-binding protein; h-FABPpM, he-
patic plasma membrane FABP; GOT, glutamic-oxaloacetic transam-
inase; mGOT, mitochondrial isoenzyme of GOT.
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pernatants were screened and assayed for antibody activity
by an ELISA technique employing an alkaline phosphatase-
conjugated goat anti-mouse immunoglobulin (Sigma) as the
second antibody.
Immunofluorescence and Immuno Electron Microscopy.
The distribution of mGOT and h-FABPpM in acetone-fixed
cryostat sections of snap-frozen rat liver was determined by
the indirect fluorescence antibody technique, using rabbit
antisera against the two proteins as primary antibodies and
fluorescein-conjugated sheep anti-rabbit gamma globulin as
the second antibody (20). Immuno electron microscopy of rat
liver sections was performed by standard techniques (21),
employing the same primary antibodies and a colloidal gold-
conjugated second antibody. ELISA-positive monoclonal
antibodies were further evaluated by indirect immunofluo-
rescence, employing single-cell suspensions of rat hepato-
cytes isolated by collagenase perfusion (22). For some im-
munofluorescence studies, employing both rabbit antisera
and monoclonal antibodies, antibodies were incubated with
antigen prior to their use.
Cellular Fatty Acid Uptake and Antibody Inhibition. The
uptake of [3H]oleate by isolated hepatocytes was studied by
a rapid filtration technique (23). Sulfobromophthalein and
taurocholate uptake studies employed [35S]sulfobromo-
phthalein (a gift of Allan W. Wolkoff, Albert Einstein College
of Medicine, Bronx, NY) and [14Cltaurocholate and were
conducted under the same conditions as those employed for
oleate (24). Antibody inhibition studies were performed with
cells preincubated for 1 hr on ice with the appropriate
antibody, washed, and resuspended in Hanks' Hepes buffer,
pH 7.4, as previously described (24). Finally, the effect on
oleate uptake of preincubating the antibody with antigen was
tested by adding 150 ,ug ofmGOT to 300 ,ul of anti-h-FABPpM
immune rabbit serum at room temperature for 30 min before
antiserum was added to the cells. The appropriate control
(preimmune serum) and a separate aliquot of the antiserum
were incubated at room temperature with an equivalent
volume of buffer. In all cases, uptake of ligands was esti-
mated from the slope of the initial, linear portion of their
cumulative uptake curves. These techniques afford an accu-
rate measure of initial influx rates for a variety of ligands and
in various cell types, including hepatocytes (10, 11, 25, 26).
Labeling of Cell Surface Proteins in Vitro. Hepatocytes in
overnight monolayer cultures were radiolabeled (125I) with
lactoperoxidase at 4°C, conditions under which only cell
surface components would be expected to be labeled (27).
Specific immunoadsorbents were prepared by mixing 0.75 ml
of protein A-Sepharose suspension (containing 2 mg of pro-
tein A per ml of swollen gel) with 0.25 ml of rabbit anti-rat
mGOT, h-FABPpM, plasma membrane sulfobromophtha-
lein/bilirubin-binding protein (26), albumin, transferrin, or
ligandin antiserum. This mixture was diluted to a final volume
of 2 ml with IP buffer (0.5% Nonidet P-40/0.1% SDS/0.15 M
NaCl/1 mM EDTA/0.1 mM phenylmethylsulfonyl fluoride/
10 mM Tris HCl, pH 7.5) and incubated at 4°C on a roller
mixer. Each gel was then washed four times in IP buffer and
resuspended to a total volume of 2 ml for use. At the
termination of the iodination reaction, the cells were scraped
from the culture dishes and resuspended in 4 ml of IP buffer,
briefly sonicated in a cup horn (Branson sonicator), and
centrifuged at 50 x g to remove unbroken cells and debris;
the pellet was discarded. The supernatant was mixed with 20
,ug each of rat transferrin and albumin and an equal volume
ofIP buffer, incubated on ice for 15 min, and then centrifuged
at 15,000 x g for 15 min. Duplicate 0.2-ml aliquots were
mixed with 0.1 ml of the appropriate protein A immunoad-
sorbent in 1.5-ml screw-cap tubes, and a further 1 ml of IP
buffer was added to each tube. The tubes were incubated at
40C overnight on a roller mixer. The protein A-Sepharose was
pelleted by centrifugation at 10,000 x g for 5 min and washed
three times with IP buffer, prior to measurement of radioac-
tivity in a y-counting spectrometer. Total counts were deter-
mined from 0.2-ml aliquots of the sonicated lysates. Counts
due to nonspecific binding, determined using a protein A-
nonimmune rabbit IgG complex, were subtracted from the
counts in the specific immunoprecipitates.
RESULTS
h-FABPpM Preparations. h-FABPpM samples purified ei-
ther by procedure A, by procedure B, or by the one-step
affinity chromatography procedure reported earlier (7) were
electrophoretically indistinguishable and gave a single pre-
cipitin line of identity in Ouchterlony studies employing a
polyclonal rabbit antiserum raised against an antigen pre-
pared by procedure A. Purity of h-FABPpM prepared by
procedure A or B invariably exceeded 98%. For procedure B,
recovery, as assessed by GOT enzymatic activity (see be-
low), was 48 ± 6% of the GOT activity measured in the
starting membranes.
Amino Acid Composition and Sequence. The experimen-
tally determined amino acid composition of highly purified
h-FABPpM is similar to that reported previously (14, 28, 29)
for rat livermGOT or deduced from cDNA sequences (30, 31)
(Table 1). With respect to amino acid sequencing, neither
sequencing facility was able to define with certainty the
N-terminal amino acids at positions 1 and 2, due to the
presence of free amino acids in the submitted samples.
However, the 22 subsequent residues were identical to the
corresponding amino acids of mGOT (14, 30).
Electrophoretic and Chromatographic Behavior. Purified
mGOT and plasma membrane FABPs from rat liver (8),
jejunum (9), adipose tissue (10), and cardiac muscle (8, 11)
migrated identically during SDS/PAGE (Fig. 1), with an
estimated molecular mass of 43 kDa. Both mGOT and
h-FABPpM were highly basic, and each demonstrated a
similar pattern of charge isomers, with an average isoelectric
point centered at pH 9.1 (Fig. 1). The two proteins also
demonstrated identical behavior in four distinctly different
HPLC columns: hydroxyapatite, reverse phase, hydropho-
bic interaction, and gel permeation (Fig. 2).
Enzymatic Activity of 1-FABPpM. The plasma membrane
preparation from which h-FABPpM was purified possessed
Table 1. Amino acid (AA) composition of h-FABPpM and mGOT
No. of residues per mol of protein*
mGOT
h-FABPpM From cDNA AA analysis AA analysis
AA AA analysis (ref. 30) (ref. 14) (ref. 29)
Asx 35 36 36 32
Glx 39 39 43 45
Ser 23 23 22 22
Gly 34 35 36 32
His 9 9 8 8
Arg 23 20 19 17
Thr 17 19 17 16
Ala 33 33 33 29
Pro 21 19 19 14
Tyr 12 12 12 11
Val 29 28 29 28
Met 10 10 10 13
Cys ND 7 8 ND
Ile 18 19 19 15
Leu 33 32 31 30
Phe 19 19 19 24
Lys 29 30 27 43
Trp ND 7 9 ND
*Calculation based on Mr = 44,000; ND, not determined.
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FIG. 1. (Left) SDS/PAGE of purified mGOT (lane 1) and plasma
membrane FABPs from rat hepatocytes (lane 2), jejunal enterocytes
(lane 3), adipocytes (lane 4), and cardiomyocytes (lane 5). Size
standards are shown in lane 6. (Right) Analytical isoelectric focusing
ofh-FABPpM and mGOT. Proteins were visualized by silver staining
(8).
GOT enzymatic activity (mean 2.8 units/mg of membrane
protein) that was enriched 3- to 4-fold compared to that of
whole rat liver homogenate; conversely, the activity in the
same membranes of the conventional mitochondrial marker
succinate dehydrogenase was consistently <25% of its value
in the homogenate. During chromatographic purification of
h-FABPpM by HPLC, a peak ofGOT activity was recovered
from each of the columns and corresponded in each instance
to the elution profile of the h-FABPpM. The specific activity
ofthe purified protein, 140-180 units/mg of protein, is similar
to reported values for mGOT of 100-230 units/mg (14, 32).
From the relative GOT specific activities of h-FABPpM and
liver plasma membranes, we estimate that h-FABPpM con-
stitutes 1-2% ofplasma membrane protein in rat hepatocytes.
mGOT was retained on and eluted from oleate-agarose af-
finity chromatography columns similarly to h-FABPpM (data
not shown). In addition, studies of the binding of [3H]oleate
to h-FABPpM and mGOT were carried out according to Glatz
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FIG. 2. Elution of h-FABPpM and mGOT from four different
HPLC columns. In each case the proteins were run in immediate
succession under identical conditions with respect to flow rates and
solvent and salt gradients.
FIG. 3. Western blots probed with rabbit antisera against h-
FABPpM and mGOT and three monoclonal antibodies raised against
h-FABPpM. Lanes: E, extract of liver plasma membrane proteins
(250 pg); F, purified h-FABPpM (3-5 ;Lg); G, purified mGOT (5 ,ug).
Both polyclonal antisera and monoclonal antibodies reacted with
both h-FABPpM and mGOT.
and Veerkamp (33). When analyzed according to Scatchard
(34), each protein exhibited a single class of binding sites,
with similar association constants (mGOT, Ka = 1.2 X 107
M-1; h-FABPpM, Ka = 1.4 x 107 M-1).
Absorption Spectra. The absorption spectra of the two
proteins were strikingly similar. In acid (pH 4.8) each had an
absorption maximum at 435 nm (mGOT, e0 = 3.8 X 103
M'LCm-1; h-FABPpM, E0 = 4.5 x 10i M-1 cm-1); at pH 2
8.3, the absorption maximum shifted to 354 nm as previously
reported for mGOT (35) (mGOT, E0 = 8.6 x 103 M-1 cm-l;
h-FABPpM, E0 = 8.0 X 103 M-1'cm-1).
Immunologic Relationships. Monospecific rabbit antiserum
raised against rat mGOT also reacted by both immunodiffu-
sion and immunoblot against h-FABPpM, and vice versa (Fig.
3). A total of 13 monoclonal cell lines producing an anti-
h-FABPpM have been identified thus far by ELISA screening.
Of the monoclonal antibodies evaluated in more detail, three
(4A4, 5C1, and 8C1) gave positive plasma membrane immu-
nofluorescence when freshly isolated hepatocytes were used
as targets. Each of these three monoclonal antibodies iden-
tified both h-FABPpM and mGOT in Western blots (Fig. 3).
Immunofluorescence Studies. Both rabbit anti-h-FABPpM
and anti-mGOT produced marked, specific plasma mem-
brane immunofluorescence in slices offreshly frozen rat liver
(Fig. 4), which was lacking in similar studies performed with
the preimmune sera. The presence of anti-mGOT bound to
FIG. 4. Immunofluorescence of rat liver sections with rabbit
anti-rat inGOT (Left) or anti-h-FABPPM (Right) as primary antibody
and fluoresceinated anti-rabbit immunoglobulins as secondary anti-
body. Both antisera gave specific plasma membrane staining as well
as punctate cytoplasmic staining, which were lacking in studies with
preimmune sera.
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FIG. 5. Effects of anti-h-FABPpM (A), anti-mGOT (o), and preimmune serum (o) on hepatocellular uptake of [3H]oleate (Left) and[35S]sulfobromophthalein (35S-BSP) and ['4C]taurocholate (Right). Both antisera noncompetitively inhibited oleate uptake but had no effect on
the uptake of the other two organic anions studied. Compared to the control study of specific oleate uptake [Vmax = 100 ± 6 pmol/min per 50,000
cells (mean + SD, n = 3), Km = 100 ± 16 nM], anti-h-FABPpM and anti-mGOT reduced Vm to 66 ± 5 (P < 0.002) and 69 ± 5 (P < 0.005),
respectively. Corresponding Km values were 125 ± 12 and 113 ± 12 (P not significant). BSA, bovine serum albumin.
plasma membranes and of anti-h-FABPpM bound to mito-
chondria was confirmed by immuno electron microscopy
using a colloidal gold-conjugated second antibody. The
plasma membrane immunofluorescence produced with anti-
mGOT could be eliminated by preincubation ofthe antiserum
for 30 min at room temperature with purified h-FABPpM.
Similarly, the plasma membrane immunofluorescence pro-
duced with anti h-FABPpM was eliminated when the antise-
rum had been absorbed with mGOT (data not shown).
Cellular Fatty Acid Uptake Studies. When diluted to an
identical IgG concentration of 1 mg/ml, anti-h-FABPpM and
anti-mGOT produced similar inhibitory effects on the hepa-
tocellular uptake of [3H]oleate but had no effect on the uptake
of [35S]sulfobromophthalein or [14C]taurocholate (Fig. 5).
The inhibitory effect of both antisera on oleate uptake was
noncompetitive. In the particular study illustrated, each
produced an -35% reduction in Vm,, but had no effect on K.,
compared to control studies employing an equivalent con-
centration of preimmune serum. As with the membrane
immunofluorescence, the ability of anti-h-FABPpM to inhibit[3H]oleate uptake could be blocked by prior incubation ofthe
antibody with mGOT.
Cell Surface Labeling Studies. Immunoprecipitates of three
plasma membrane proteins, h-FABPpM, plasma membrane
sulfobromophthalein/bilirubin-binding protein, and transfer-
rin receptor (bound to transferrin and precipitated with
anti-transferrin) contained 0.39 ± 0.06%, 0.57 ± 0.06%, and
0.63 ± 0.16% of the input radioactivity, respectively (n = 10).
By contrast, only 0.02 ± 0.01% of the input radioactivity was
recovered with the protein A-anti-albumin immunoadsor-
bent. Radioactivity recovered in the protein A-anti-ligandin
immunoadsorbent was only 4-7% of that recovered in the
three membrane protein immunoprecipitates and did not
differ from the nonspecifically bound radioactivity recovered
with the protein A-anti-IgG adsorbent (Student's t test; P >
0.2) confirming that intracellular proteins were not labeled
under the conditions of this experiment. Comparable results
were obtained in a separate study employing hepatocyte
single-cell suspensions in lieu of hepatocyte monolayer cul-
tures.
DISCUSSION
The paragraphs above present data on amino acid composi-
tion, N-terminal sequence, electrophoretic and chromato-
graphic behavior, absorption spectra, enzymatic activity,
fatty acid binding characteristics, immunologic relationships,
and subcellular distribution all pointing to the conclusion that
the h-FABPpM isolated from liver plasma membranes and
mGOT are very similar. This conclusion is supported by the
covalent labeling of both proteins with a [3H]labeled C18
diazarino fatty acid derivative synthesized as a photoaffinity
probe in the laboratory of G. Kurz (G. Stoll and G. Kurz,
personal communication). Although mGOT, once released
from mitochondria, may bind nonspecifically to a variety of
lipid structures including cell membranes (36-38), four lines
of evidence suggest that the h-FABPpM isolated from plasma
membranes is indigenous to that subcellular location and is
not merely the result of mitochondrial contamination. (i) The
plasma membranes from which h-FABPpM was extracted
were enriched in GOT activity, whereas the activity in the
membranes of the conventional mitochondrial marker en-
zyme succinate dehydrogenase was reduced. (ii) Immuno-
histologic studies demonstrated the presence of h-FABPpM/
mGOT antigens in hepatocyte plasma membranes as well as
intracellularly. (iii) Cell surface labeling studies with freshly
isolated hepatocyte suspensions and monolayer cultures,
under conditions that do not label intracellular proteins, led
to appreciable labeling of h-FABPpM. (iv) Rabbit anti-rat
h-FABPpM and anti-rat mGOT selectively inhibited the
plasma membrane transport system for free fatty acid uptake
but had no effect on the analogous but distinct membrane
transport systems for sulfobromophthalein and taurocholate.
Since taurocholate uptake is a sodium-coupled secondary
active process critically dependent on maintenance of an
adequate intracellular ATP supply (reviewed in ref. 39), the
latter data suggest that the antibody-mediated inhibition of
fatty acid uptake was not the result of mitochondrial injury.
Nuclear-encoded mitochondrial proteins typically are syn-
thesized on free cytosolic ribosomes as larger precursors
containing N-terminal mitochondrial presequences or signal
peptides (40, 41). mGOT is a well studied example of such a
mitochondrial protein (42-50), and cDNAs for both the
mature rat enzyme (31) and its larger precursor (30, 51) have
been cloned. For mGOT to be identical to a plasma mem-
brane protein would pose interesting questions in cell and
molecular biology. A close similarity, if not identity, between
another plasma membrane protein, organic anion-binding
protein, and the , subunit of the mitochondrial F1 ATP
synthase has been suggested (52).
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Despite the obvious similarities noted above, mGOT and
h-FABPpM may not be identical. One of our monoclonal
antibodies, 5C2, reacts strongly on Western blots with h-
FABPpM, but only weakly and inconsistently with mGOT. In
nuclease protection assays with rat liver mRNA, employing
as a probe a 252-base-pair fragment at the 5' end of an
authentic mGOT cDNA (the cDNA clone was kindly pro-
vided by J. R. Mattingly; ref. 30), two bands are seen: one
corresponding to the intact probe and one of =125 base pairs.
This suggests that, in addition to an mGOT mRNA, rat liver
contains an mRNA that is identical over a region sufficient to
code for c40 amino acids but then contains a mismatch of
thus far undetermined extent. Finally, immunoscreening of
rat liver cDNA libraries has identified, in addition to cDNA
clones for mGOT, a crossreacting pUC8 clone, designated
pm-1. The -800-base-pair pm-1 cDNA insert includes a
poly(A) region and thus represents the 3' end of the 2.4-
kilobase mRNA in rat liver to which it hybridizes on North-
ern blots. Although this is the same size as mGOT mRNA, the
restriction maps of pm-1 and mGOT cDNA differ. Because
pm-1 encodes for the C-terminal end of a protein and amino
acid sequence data for h-FABPpM are thus far available only
for an N-terminal region, their relationship remains to be
established.
At the present time, available data indicate that h-FABPpM
and mGOT are strikingly similar. Clarification of the basis for
these similarities will require further studies at both the
protein and the nucleic acid level.
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